ZUMA Trial program

The ZUMA Trial program is a series of clinical studies designed to evaluate the safety and effectiveness of a type of cancer treatment known as CAR T-cell therapy. This therapy involves modifying a patient’s own immune cells to better target and attack cancer cells, particularly for certain types of blood cancers like lymphoma and leukemia. The trials gather data to understand how well this treatment works, its side effects, and how it can be improved. Successful results from these studies could lead to new, effective options for patients who have not responded well to conventional treatments.